journal
MENU ▼
Read by QxMD icon Read
search

European Heart Journal

journal
https://read.qxmd.com/read/31298266/rhythm-control-for-patients-with-atrial-fibrillation-complicated-with-heart-failure-in-the-contemporary-era-of-catheter-ablation-a-stratified-pooled-analysis-of-randomized-data
#1
Shaojie Chen, Helmut Pürerfellner, Christian Meyer, Willem-Jan Acou, Alexandra Schratter, Zhiyu Ling, Shaowen Liu, Yuehui Yin, Martin Martinek, Marcio G Kiuchi, Boris Schmidt, K R Julian Chun
AIMS: The optimal treatment for patients with atrial fibrillation (AF) and heart failure (HF) has been a subject of debate for years. We aimed to evaluate the efficacy and safety of rhythm control strategy in patients with AF complicated with HF regarding hard clinical endpoints. METHODS AND RESULTS: Up-to-date randomized data comparing rhythm control using antiarrhythmic drugs (AADs) vs. rate control (Subset A) or rhythm control using catheter ablation vs. medical therapy (Subset B) in AF and HF patients were pooled...
July 11, 2019: European Heart Journal
https://read.qxmd.com/read/31292627/reply-to-the-commentary-prevalence-and-correlates-of-coronary-microvascular-dysfunction-in-heart-failure-with-preserved-ejection-fraction-promis-hfpef
#2
William D Watson
No abstract text is available yet for this article.
July 10, 2019: European Heart Journal
https://read.qxmd.com/read/31292626/recommendations-for-participation-in-competitive-sport-in-athletes-with-hypertrophic-cardiomyopathy-opening-the-sacks-of-aeolus
#3
Efstathios D Pagourelias, Evaggelia Kouidi, Vassilios P Vassilikos
No abstract text is available yet for this article.
July 10, 2019: European Heart Journal
https://read.qxmd.com/read/31292614/inhibition-of-pro-inflammatory-myeloid-cell-responses-by-short-term-s100a9-blockade-improves-cardiac-function-after-myocardial-infarction
#4
Goran Marinković, Helena Grauen Larsen, Troels Yndigegn, Istvan Adorjan Szabo, Razvan Gheorghita Mares, Lisa de Camp, Matthew Weiland, Lukas Tomas, Isabel Goncalves, Jan Nilsson, Stefan Jovinge, Alexandru Schiopu
AIMS: Neutrophils have both detrimental and beneficial effects in myocardial infarction (MI), but little is known about the underlying pathways. S100A8/A9 is a pro-inflammatory alarmin abundantly expressed in neutrophils that is rapidly released in the myocardium and circulation after myocardial ischaemia. We investigated the role of S100A8/A9 in the innate immune response to MI. METHODS AND RESULTS: In 524 patients with acute coronary syndrome (ACS), we found that high plasma S100A8/A9 at the time of the acute event was associated with lower left ventricular ejection fraction (EF) at 1-year and increased hospitalization for heart failure (HF) during follow-up...
July 10, 2019: European Heart Journal
https://read.qxmd.com/read/31292610/four-dimensional-flow-cardiac-magnetic-resonance-visualization-and-quantification-of-a-large-coronary-fistula
#5
Lisa Guirgis, Marielle Gouton, Sébastien Hascoet, Jean-François Paul
No abstract text is available yet for this article.
July 10, 2019: European Heart Journal
https://read.qxmd.com/read/31289820/single-systemic-transfer-of-a-human-gene-associated-with-exceptional-longevity-halts-the-progression-of-atherosclerosis-and-inflammation-in-apoe-knockout-mice-through-a-cxcr4-mediated-mechanism
#6
Annibale Alessandro Puca, Albino Carrizzo, Chiara Spinelli, Antonio Damato, Mariateresa Ambrosio, Francesco Villa, Anna Ferrario, Anna Maciag, Francesco Fornai, Paola Lenzi, Valentina Valenti, Flavio di Nonno, Giulio Accarino, Michele Madonna, Maurizio Forte, Gaetano Calì, Andrea Baragetti, Giuseppe Danilo Norata, Alberico Luigi Catapano, Monica Cattaneo, Raffaele Izzo, Valentina Trimarco, Francesco Montella, Francesco Versaci, Alberto Auricchio, Giacomo Frati, Sebastiano Sciarretta, Paolo Madeddu, Elena Ciaglia, Carmine Vecchione
AIMS: Here, we aimed to determine the therapeutic effect of longevity-associated variant (LAV)-BPIFB4 gene therapy on atherosclerosis. METHODS AND RESULTS: ApoE knockout mice (ApoE-/-) fed a high-fat diet were randomly allocated to receive LAV-BPIFB4, wild-type (WT)-BPIFB4, or empty vector via adeno-associated viral vector injection. The primary endpoints of the study were to assess (i) vascular reactivity and (ii) atherosclerotic disease severity, by Echo-Doppler imaging, histology and ultrastructural analysis...
July 10, 2019: European Heart Journal
https://read.qxmd.com/read/31289825/regression-therapy-for-cardiovascular-disease
#7
Sanjay Rajagopalan, Imran Rashid
No abstract text is available yet for this article.
July 9, 2019: European Heart Journal
https://read.qxmd.com/read/31289824/successful-transfemoral-transcatheter-aortic-valve-implantation-using-the-acurate-neo-for-bicuspid-aortic-valve-stenosis
#8
Mizuki Miura, Christian Templin, Francesco Maisano, Maurizio Taramasso
No abstract text is available yet for this article.
July 9, 2019: European Heart Journal
https://read.qxmd.com/read/31289813/screening-children-at-risk-for-hypertrophic-cardiomyopathy-balancing-benefits-and-harms
#9
Christopher Semsarian, Carolyn Y Ho
No abstract text is available yet for this article.
July 9, 2019: European Heart Journal
https://read.qxmd.com/read/31280315/alk-negative-primary-cardiac-t-cell-lymphoma-coexpressing-cd3-and-cd30-in-an-immunocompetent-adult
#10
Xin Wei, Xi Li, Hong Tang, Mao Chen
No abstract text is available yet for this article.
July 6, 2019: European Heart Journal
https://read.qxmd.com/read/31280285/no-time-to-weight-obesity-through-life-and-af-risk
#11
Melissa E Middeldorp, Christopher X Wong, Celine Gallagher, Adrian D Elliott, Dennis H Lau, Prashanthan Sanders
No abstract text is available yet for this article.
July 6, 2019: European Heart Journal
https://read.qxmd.com/read/31280324/the-international-calmodulinopathy-registry-recording-the-diverse-phenotypic-spectrum-of-un-calm-hearts
#12
Mette Nyegaard, Michael T Overgaard
No abstract text is available yet for this article.
July 5, 2019: European Heart Journal
https://read.qxmd.com/read/31280286/focal-and-multifocal-renal-artery-fibromuscular-dysplasia
#13
Daniella Kadian-Dodov, Robert Lookstein, Jeffrey W Olin
No abstract text is available yet for this article.
July 5, 2019: European Heart Journal
https://read.qxmd.com/read/31280284/variability-in-aspirin-efficacy-all-in-the-genes
#14
Colin Baigent, Michael V Holmes
No abstract text is available yet for this article.
July 5, 2019: European Heart Journal
https://read.qxmd.com/read/31274157/management-of-cardiogenic-shock-complicating-myocardial-infarction-an-update-2019
#15
Holger Thiele, E Magnus Ohman, Suzanne de Waha-Thiele, Uwe Zeymer, Steffen Desch
Cardiogenic shock (CS) remains the most common cause of death in patients admitted with acute myocardial infarction (AMI) and mortality remained nearly unchanged in the range of 40-50% during the last two decades. Early revascularization, vasopressors and inotropes, fluids, mechanical circulatory support, and general intensive care measures are widely used for CS management. However, there is only limited evidence for any of the above treatment strategies except for revascularization and the relative ineffectiveness of intra-aortic balloon pumping...
July 4, 2019: European Heart Journal
https://read.qxmd.com/read/31274156/a-new-diastolic-dysfunction-disease-modelling-platform
#16
Shambhabi Chatterjee, Thomas Thum
No abstract text is available yet for this article.
July 4, 2019: European Heart Journal
https://read.qxmd.com/read/31270529/efficacy-and-safety-of-alirocumab-and-evolocumab-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials
#17
Paul Guedeney, Gennaro Giustino, Sabato Sorrentino, Bimmer E Claessen, Anton Camaj, Deborah N Kalkman, Birgit Vogel, Samantha Sartori, Salvatore De Rosa, Usman Baber, Ciro Indolfi, Gilles Montalescot, George D Dangas, Robert S Rosenson, Stuart J Pocock, Roxana Mehran
AIMS: The effect of low-density lipoprotein cholesterol-lowering therapy with alirocumab or evolocumab on individual clinical efficacy and safety endpoints remains unclear. We aimed to evaluate the efficacy and safety of alirocumab and evolocumab in patients with dyslipidaemia or atherosclerotic cardiovascular disease. METHODS AND RESULTS: We performed a review of randomized controlled trials (RCTs) comparing treatment with alirocumab or evolocumab vs. placebo or other lipid-lowering therapies up to March 2018...
July 3, 2019: European Heart Journal
https://read.qxmd.com/read/31292611/corrigendum-to-2018-esc-eacts-guidelines-on-myocardial-revascularization
#18
(no author information available yet)
No abstract text is available yet for this article.
July 2, 2019: European Heart Journal
https://read.qxmd.com/read/31263876/kidney-injury-is-not-prevented-by-hydration-alone
#19
Jay Koyner, George Bakris
No abstract text is available yet for this article.
July 1, 2019: European Heart Journal
https://read.qxmd.com/read/31263875/mapping-human-pluripotent-stem-cell-endothelial-cell-differentiation-using-scrna-seq-a-step-towards-therapeutic-angiogenesis
#20
Alexander R Pinto, Alex Bobik
No abstract text is available yet for this article.
July 1, 2019: European Heart Journal
journal
journal
20101
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"